Study Details

Back
Study ID 4901-CL-0201
Study Title A Phase 2, Randomized, Double-blind, Placebo-controlled, Active-referenced, Parallel-group Comparative Study of ASP4901 in Patients with Benign Prostatic Hyperplasia: Proof-of-concept Study
Clinicaltrials.gov Identifier NCT02038868
Compound Name ASP4901
Medical Indication or Disease Benign prostatic hyperplasia
Study Sponsor Astellas Pharma Inc.
Collaborator Not Applicable
Study Start Date 22-Jul-2013
Study Completion Date 04-Apr-2014
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
Japanese

QUICK SEARCH

USEFUL LINKS